Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7902)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2015 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Waluga M, Kukla M, Żorniak M, Bacik A, Kotulski R. From the stomach to other organs: |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i18/2136.htm |
| Number | Citing Articles |
| 1 |
Liming Qiang, Jianguo Hu, Mingyuan Tian, Yu Li, Chao Ren, Yi Deng, Yuan Jiang. Extracellular vesicles from helicobacter pylori‐infected cells and helicobacter pylori outer membrane vesicles in atherosclerosis. Helicobacter 2022; 27(2) doi: 10.1111/hel.12877
|
| 2 |
Banchob Sripa, Raksawan Deenonpoe, Paul J. Brindley. Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma?. Parasitology International 2017; 66(4): 383 doi: 10.1016/j.parint.2016.11.016
|
| 3 |
Zeyu Wang, Weijun Wang, Rui Gong, Hailing Yao, Mengke Fan, Junchao Zeng, Sanping Xu, Rong Lin. Eradication of Helicobacter pylori alleviates lipid metabolism deterioration: a large-cohort propensity score-matched analysis. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01639-5
|
| 4 |
Yousry Esam-Eldin Abo-Amer, Aisha Sabal, Rehab Ahmed, Nabil Fathy Esmael Hasan, Rasha Refaie, Sahar Mohamed Mostafa, Ahmed Abdelhaleem Mohamed, Mahmoud Khalil, Waleed Elagawy, Sherief Abd-Elsalam. <p>Relationship Between <em>Helicobacter pylori</em> Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study</p>. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; : 619 doi: 10.2147/DMSO.S237866
|
| 5 |
Ahmed Abdel-Razik, Nasser Mousa, Rania Elhelaly, Rasha Elzehery, Ahmad S. Hasan, Mostafa Abdelsalam, Ahmed Salah Seif, Ahmed M. Tawfik, Niveen El-Wakeel, Waleed Eldars. Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00096
|
| 6 |
Maria Luísa Cordeiro Santos, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Mariana Miranda Sampaio, Hanna Santos Marques, Natália Oliveira e Silva, Dulciene Maria de Magalhães Queiroz, Fabrício Freire de Melo. <i>Helicobacter pylori</i> infection: Beyond gastric manifestations. World Journal of Gastroenterology 2020; 26(28): 4076-4093 doi: 10.3748/wjg.v26.i28.4076
|
| 7 |
Mahnaz Mohammadi, Adeleh Attar, Maryam Mohammadbeigi, Amir Peymani, Shahin Bolori, Fatemeh Fardsanei. The possible role of Helicobacter pylori in liver diseases. Archives of Microbiology 2023; 205(8) doi: 10.1007/s00203-023-03602-z
|
| 8 |
|
| 9 |
David Porras, Esther Nistal, Susana Martínez-Flórez, Sandra Pisonero-Vaquero, José Luis Olcoz, Ramiro Jover, Javier González-Gallego, María Victoria García-Mediavilla, Sonia Sánchez-Campos. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radical Biology and Medicine 2017; 102: 188 doi: 10.1016/j.freeradbiomed.2016.11.037
|
| 10 |
Cheng‐En Tsai, Chih‐Ming Liang, Chen‐Hsiang Lee, Yuan‐Hung Kuo, Keng‐Liang Wu, Yi‐Chun Chiu, Wei‐Chen Tai, Seng‐Kee Chuah. First‐line Helicobacter pylori eradication among patients with chronic liver diseases in Taiwan. The Kaohsiung Journal of Medical Sciences 2016; 32(8): 397 doi: 10.1016/j.kjms.2016.05.012
|
| 11 |
Osman Özdoğan, Serkan Yaras. Helicobacter pylori rate and histopathological evaluation in HBeAg-negative chronic hepatitis B virus infection. Archives of Medical Science – Civilization Diseases 2019; 4(1): 97 doi: 10.5114/amscd.2019.91449
|
| 12 |
Zhiyuan Ma, Xiajing Chu, Xiang Yan, Wenjin Wang. Association between Helicobacter pylori infection and non-alcoholic fatty liver disease for Asian and non-Asian population: A systematic review and meta-analysis. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.1062942
|
| 13 |
Neveen Rashad Mostafa, Abeer A.M. Ali, Mona Gamalludin Alkaphoury, Roy Rillera Marzo. <i>Helicobacter Pylori</i> infection and non-alcoholic fatty liver disease. Is there a relationship?. Healthcare in Low-resource Settings 2023; 11(1) doi: 10.4081/hls.2023.11379
|
| 14 |
Kazuya Okushin, Takeya Tsutsumi, Kazuhiko Ikeuchi, Akira Kado, Kenichiro Enooku, Hidetaka Fujinaga, Kyoji Moriya, Hiroshi Yotsuyanagi, Kazuhiko Koike. <i>Helicobacter pylori</i> infection and liver diseases: Epidemiology and insights into pathogenesis. World Journal of Gastroenterology 2018; 24(32): 3617-3625 doi: 10.3748/wjg.v24.i32.3617
|
| 15 |
Linghua Yu, Linlin Wang, Huixing Yi, Xiaojun Wu. Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model. Gut Microbes 2020; 11(4): 1015 doi: 10.1080/19490976.2020.1736457
|
| 16 |
Sailimai Man, Yuan Ma, Cheng Jin, Jun Lv, Mingkun Tong, Bo Wang, Liming Li, Yi Ning. Association between Helicobacter pylori Infection and Diabetes: A Cross-Sectional Study in China. Journal of Diabetes Research 2020; 2020: 1 doi: 10.1155/2020/7201379
|
| 17 |
Subhasish Sahoo, Diptirani Rath, Durga Madhab Kar, Sovan Pattanaik. Hepatoprotective potency of Litsea glutinosa (L.) C.B. Rob. leaf methanol extract on H2O2-induced toxicity in HepG2 cells. Journal of Ethnopharmacology 2023; 304: 116076 doi: 10.1016/j.jep.2022.116076
|
| 18 |
Christian S. Alvarez, Andrea A. Florio, Julia Butt, Alvaro Rivera‐Andrade, María F. Kroker‐Lobos, Tim Waterboer, Maria Constanza Camargo, Neal D. Freedman, Barry I. Graubard, Mariana Lazo, Eliseo Guallar, John D. Groopman, Manuel Ramírez‐Zea, Katherine A. McGlynn. Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala. Helicobacter 2020; 25(6) doi: 10.1111/hel.12756
|
| 19 |
Karl Aramouni, Roland K. Assaf, Maria Azar, Karen Jabbour, Abdullah Shaito, Amirhossein Sahebkar, Assaad A. Eid, Manfredi Rizzo, Ali H. Eid. Infection with Helicobacter pylori may predispose to atherosclerosis: role of inflammation and thickening of intima-media of carotid arteries. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1285754
|
| 20 |
婷婷 李. The Mechanism of Nonalcoholic Fatty Liver Disease Induced by Helicobacter pylori Infection. Advances in Clinical Medicine 2021; 11(09): 3865 doi: 10.12677/ACM.2021.119566
|
| 21 |
Chang-Hai Liu, Wei Jiang, Dong-Bo Wu, Qing-Min Zeng, You-Juan Wang, Hong Tang. Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection. Digestive Diseases and Sciences 2023; 68(4): 1605 doi: 10.1007/s10620-022-07695-2
|
| 22 |
Juan Wang, Ruo-Chan Chen, Yi-Xiang Zheng, Shu-Shan Zhao, Ning Li, Rong-Rong Zhou, Yan Huang, Ze-Bing Huang, Xue-Gong Fan. Helicobacter pylori infection may increase the risk of progression of chronic hepatitis B disease among the Chinese population: a meta-analysis. International Journal of Infectious Diseases 2016; 50: 30 doi: 10.1016/j.ijid.2016.07.014
|
| 23 |
Diana V. Ávila-Martínez, Wendy K. Mixtega-Ruiz, José M. Hurtado-Capetillo, Oscar Lopez-Franco, Mónica Flores-Muñoz. Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1377113
|
| 24 |
Shefali Amin, Biraj Shrestha, Ameya Deshmukh, Manish Shrestha, Parth Desai, John Altomare. Helicobacter pylori Infection and Complications of Cirrhosis. Cureus 2024; doi: 10.7759/cureus.54419
|
| 25 |
Niki Katsiki, Dimitri P. Mikhailidis, Christos Mantzoros. Non-alcoholic fatty liver disease and colorectal cancer: A marker of risk or common causation?. Metabolism 2018; 87: A10 doi: 10.1016/j.metabol.2018.08.003
|
| 26 |
Natalia Castaño-Rodríguez, Hazel M. Mitchell, Nadeem O. Kaakoush. NAFLD, Helicobacter species and the intestinal microbiome. Best Practice & Research Clinical Gastroenterology 2017; 31(6): 657 doi: 10.1016/j.bpg.2017.09.008
|
| 27 |
S. V. German, I. P. Bobrovnitsky. Helicobacter pylori Infection and Hepatobiliary Pathology. Rossijskij žurnal gastroènterologii gepatologii koloproktologii 2018; 28(4): 15 doi: 10.22416/1382-4376-2018-28-4-15-22
|
| 28 |
Paulius Jonaitis, Juozas Kupcinskas, Javier P. Gisbert, Laimas Jonaitis. Helicobacter pylori Eradication Treatment in Older Patients. Drugs & Aging 2024; 41(2): 141 doi: 10.1007/s40266-023-01090-w
|
| 29 |
Oktay BULUR, Evrim Kahramanoğlu AKSOY, Gülçin GÜLER ŞİMŞEK, Murat ESER, Zeliha ASİLTÜRK LÜLLECİ, Kürşat DAL, Metin UZMAN. The Relationship Between Severity of Gastric Inflammation Due to Helicobacter pylori and Colorectal Malignancies. Cumhuriyet Medical Journal 2021; doi: 10.7197/cmj.980147
|
| 30 |
Koichi Hata, Teruhide Koyama, Etsuko Ozaki, Nagato Kuriyama, Shigeto Mizuno, Daisuke Matsui, Isao Watanabe, Ritei Uehara, Yoshiyuki Watanabe. Assessing the Relationship between Helicobacter pylori and Chronic Kidney Disease. Healthcare 2021; 9(2): 162 doi: 10.3390/healthcare9020162
|
| 31 |
Ancuta Lupu, Ingrith Crenguta Miron, Anca Lavinia Cianga, Andrei Tudor Cernomaz, Vasile Valeriu Lupu, Cristina Gavrilovici, Iuliana Magdalena Stârcea, Elena Tarca, Dragos Catalin Ghica, Silvia Fotea. The Prevalence of Liver Cytolysis in Children with Helicobacter pylori Infection. Children 2022; 9(10): 1498 doi: 10.3390/children9101498
|
| 32 |
Andriy Cherkas, Kamelija Zarkovic, Ana Cipak Gasparovic, Morana Jaganjac, Lidija Milkovic, Orest Abrahamovych, Ostap Yatskevych, Georg Waeg, Olha Yelisyeyeva, Neven Zarkovic. Amaranth oil reduces accumulation of 4-hydroxynonenal-histidine adducts in gastric mucosa and improves heart rate variability in duodenal peptic ulcer patients undergoing Helicobacter pylori eradication. Free Radical Research 2018; 52(2): 135 doi: 10.1080/10715762.2017.1418981
|
| 33 |
Pezhman Alavinejad, Morteza Nayebi, Abazar Parsi, Eman Abdelsameea, Mohammed Hussien Ahmed, Ahmad Hormati, Dao Viet Hang, Mehdi Pezeshgi Modarres, Bahman Cheraghian, Siamak Baghaee, Tahmine Farbod Ara, Quang Trung Tran, Nitin Shanker Behl, Seyed Jalal Hashemi, Mohammed Alboraie, Saif Salman, Le Nha, Árpád V. Patai, Eskandar Hajiani, Ali Akbar Abravesh. Levofloxacin+Tetracycline Quadruple Regimen for Eradication of Helicobacter pylori: A Multicenter Multinational Randomized Controlled Trial. Middle East Journal of Digestive Diseases 2023; 15(1): 12 doi: 10.34172/mejdd.2023.314
|
| 34 |
M A Kazakova, O K Pozdeev, Yu V Valeeva, L G Morozova, R A Fayzullina. Species spectrum of microflora of upper digestive tract mucosa and its effect on the development of pathology in children. Kazan medical journal 2017; 98(4): 557 doi: 10.17750/KMJ2017-557
|
| 35 |
Chen Chen, Caiyun Zhang, Xuelin Wang, Feijuan Zhang, Ze Zhang, Pengchai Ma, Shuzhi Feng. Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. European Journal of Gastroenterology & Hepatology 2020; 32(7): 857 doi: 10.1097/MEG.0000000000001601
|
| 36 |
Li-juan Lu, Ning-Bo Hao, Jian-Jun Liu, Xue Li, Rui-Ling Wang. Correlation between Helicobacter pylori Infection and Metabolic Abnormality in General Population: A Cross-Sectional Study. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/7410801
|
| 37 |
Antonietta Gerarda Gravina, Rocco Maurizio Zagari, Cristiana De Musis, Lorenzo Romano, Carmelina Loguercio, Marco Romano. <i>Helicobacter pylori</i> and extragastric diseases: A review. World Journal of Gastroenterology 2018; 24(29): 3204-3221 doi: 10.3748/wjg.v24.i29.3204
|
| 38 |
Congwei Gu, Zihan Zhou, Zehui Yu, Manli He, Lvqin He, Zhengzhong Luo, Wudian Xiao, Qian Yang, Fangfang Zhao, Weiyao Li, Liuhong Shen, Jianhong Han, Suizhong Cao, Zhicai Zuo, Junliang Deng, Qigui Yan, Zhihua Ren, Mingde Zhao, Shumin Yu. The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.870785
|
| 39 |
Mohamed A. Elsebaey, Mohamed A. Tawfik, Samah A. Elshweikh, Manal Saad Negm, Mohammed H. Elnaggar, Ghada Mahmoud Alghazaly, Sherief Abd-Elsalam. Impact of Helicobacter pylori Infection on Gastric Variceal Bleeding among Patients with Liver Cirrhosis. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/6529420
|
| 40 |
S. V. Okovity, K. L. Raikhelson, A. V. Volnukhin, D. A. Kudlai. Hepatoprotective properties of glycyrrhizic acid. Experimental and Clinical Gastroenterology 2020; (12): 96 doi: 10.31146/1682-8658-ecg-184-12-96-108
|
| 41 |
Andriy Cherkas, Sergii Golota, Françoise Guéraud, Orest Abrahamovych, Christoph Pichler, Armen Nersesyan, Volodymyr Krupak, Vira Bugiichyk, Ostap Yatskevych, Mykhaylo Pliatsko, Peter Eckl, Siegfried Knasmüller. A Helicobacter pylori-associated insulin resistance in asymptomatic sedentary young men does not correlate with inflammatory markers and urine levels of 8-iso-PGF2-α or 1,4-dihydroxynonane mercapturic acid. Archives of Physiology and Biochemistry 2018; 124(3): 275 doi: 10.1080/13813455.2017.1396346
|
| 42 |
V. Wendy Setiawan, Pengxiao C. Wei, Brenda Y. Hernandez, Shelly C. Lu, Kristine R. Monroe, Loic Le Marchand, Jian Min Yuan. Reply to High hepatocellular carcinoma risk among US‐born Hispanics. Cancer 2017; 123(2): 358 doi: 10.1002/cncr.30396
|
| 43 |
Saina Shegefti, Shahin Bolori, Ali Nabavi-Rad, Hossein Dabiri, Abbas Yadegar, Kaveh Baghaei. Helicobacter pylori-derived outer membrane vesicles suppress liver autophagy: A novel mechanism for H. pylori-mediated hepatic disorder. Microbial Pathogenesis 2023; 183: 106319 doi: 10.1016/j.micpath.2023.106319
|
| 44 |
Li Wang, Zheng-Min Cao, Li-Li Zhang, Xin-can Dai, Zhen-ju Liu, Yi-xian Zeng, Xin-Ye Li, Qing-Juan Wu, Wen-liang Lv. Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.833424
|
| 45 |
Shu Li, Daoyan Wu, Mei Cao, Zhihao Yu, Mengmeng Wu, Yi Liu, Jie Zhou, Shiying Yan, Jieyun Chen, Min Huang, Jian Zhao. Effects of choline supplementation on liver biology, gut microbiota, and inflammation in Helicobacter pylori-infected mice. Life Sciences 2020; 259: 118200 doi: 10.1016/j.lfs.2020.118200
|
| 46 |
Klay Puay Khim Lim, Aaron Jia Loong Lee, Xiuting Jiang, Thomas Zheng Jie Teng, Vishal G. Shelat. The link between Helicobacter pylori infection and gallbladder and biliary tract diseases: A review. Annals of Hepato-Biliary-Pancreatic Surgery 2023; 27(3): 241 doi: 10.14701/ahbps.22-056
|
| 47 |
Albert Lecube, Silvia Valladares, Carolina López-Cano, Liliana Gutiérrez, Andreea Ciudin, José Manuel Fort, Josep Maria Reñé, Xavier Matias-Guiu, Inés de Torres, Marta Bueno, Judit Pallarés, Juan Antonio Baena, Salvatore Petta. The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori. PLOS ONE 2016; 11(11): e0166741 doi: 10.1371/journal.pone.0166741
|
| 48 |
Joanna Pogorzelska, Magda Łapińska, Alicja Kalinowska, Tadeusz W. Łapiński, Robert Flisiak. Helicobacter pylori infection among patients with liver cirrhosis. European Journal of Gastroenterology & Hepatology 2017; 29(10): 1161 doi: 10.1097/MEG.0000000000000928
|
| 49 |
Rui Gaspar, Pedro Cardoso, Tiago Ribeiro, Marco Silva, Guilherme Macedo. Does Portal Hypertension Increase the Risk of Helicobacter pylori Infection and Pre-Malignant Gastric Lesions?. Journal of Clinical Medicine 2024; 13(6): 1768 doi: 10.3390/jcm13061768
|